iZafe Group AB Series B (IZAFE-B) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.190x

Based on the latest financial reports, iZafe Group AB Series B (IZAFE-B) has a cash flow conversion efficiency ratio of -0.190x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.65 Million ≈ $-500.74K USD) by net assets (Skr24.47 Million ≈ $2.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see IZAFE-B stock market capitalisation for the company's overall valuation and market capitalisation.

iZafe Group AB Series B - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how iZafe Group AB Series B's cash flow conversion efficiency has evolved over time, based on yearly financial data.

iZafe Group AB Series B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of iZafe Group AB Series B ranked by their cash flow conversion efficiency. Explore IZAFE-B cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sapura Resources Bhd KLSE:4596	0.031x
Excellon Resources Inc. TO:EXN	-0.029x
Schroder Oriental Income Fund LSE:SOI	0.126x
Game Your Game, Inc. Common Stock NASDAQ:GYGY	0.124x
Glimpse Group Inc NASDAQ:VRAR	0.000x
Mlk Foods Public Company Ltd WAR:MLK	0.004x
Ganges Securities Limited NSE:GANGESSECU	0.035x
Grupo Televisa SAB DRC BA:TV	0.054x

Annual Cash Flow Conversion Efficiency for iZafe Group AB Series B (2012–2025)

The table below shows the annual cash flow conversion efficiency of iZafe Group AB Series B from 2012 to 2025. View iZafe Group AB Series B (IZAFE-B) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr11.69 Million ≈ $1.26 Million	Skr-14.56 Million ≈ $-1.57 Million	-1.246x	-6.74%
2024-12-31	Skr9.73 Million ≈ $1.05 Million	Skr-11.36 Million ≈ $-1.22 Million	-1.167x	-162.91%
2023-12-31	Skr25.35 Million ≈ $2.73 Million	Skr-11.26 Million ≈ $-1.21 Million	-0.444x	+19.39%
2022-12-31	Skr38.96 Million ≈ $4.19 Million	Skr-21.46 Million ≈ $-2.31 Million	-0.551x	+33.02%
2021-12-31	Skr40.73 Million ≈ $4.38 Million	Skr-33.49 Million ≈ $-3.60 Million	-0.822x	+1.40%
2020-12-31	Skr29.46 Million ≈ $3.17 Million	Skr-24.57 Million ≈ $-2.64 Million	-0.834x	-100.85%
2019-12-31	Skr36.89 Million ≈ $3.97 Million	Skr-15.32 Million ≈ $-1.65 Million	-0.415x	-197.93%
2018-12-31	Skr10.12 Million ≈ $1.09 Million	Skr-1.41 Million ≈ $-151.74K	-0.139x	+58.08%
2017-12-31	Skr11.19 Million ≈ $1.20 Million	Skr-3.72 Million ≈ $-400.22K	-0.332x	+58.28%
2016-12-31	Skr5.42 Million ≈ $582.96K	Skr-4.32 Million ≈ $-464.47K	-0.797x	-292.09%
2015-12-31	Skr8.72 Million ≈ $938.85K	Skr-1.77 Million ≈ $-190.78K	-0.203x	-121.50%
2014-12-31	Skr9.04 Million ≈ $973.08K	Skr-829.55K ≈ $-89.27K	-0.092x	-13.91%
2013-12-31	Skr11.69 Million ≈ $1.26 Million	Skr-941.32K ≈ $-101.30K	-0.081x	+6.07%
2012-12-31	Skr18.92 Million ≈ $2.04 Million	Skr-1.62 Million ≈ $-174.55K	-0.086x	--

About iZafe Group AB Series B

ST:IZAFE-B Sweden Medical Instruments & Supplies

Market Cap

$12.36 Million

Skr114.90 Million SEK

Market Cap Rank

#26600 Global

#560 in Sweden

Share Price

Skr0.28

Change (1 day)

-3.08%

52-Week Range

Skr0.26 - Skr0.72

All Time High

Skr16.60